Helius Medical Tech (NASDAQ:HSDT) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.07) by 442.86 percent. This is a 99.52 percent increase over losses of $(79.73) per share from the same period last year. The company reported quarterly sales of $2.526 million which missed the analyst consensus estimate of $3.600 million by 29.83 percent. This is a 5.77K percent increase over sales of $43.000 thousand the same period last year.